PRESS RELEASE
News
-
-
PRESS RELEASE
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics appoints Prof. John W. Krakauer as strategic advisor to support growth in the United States. Dr. Krakauer is a leading figure in motor neuroscience, stroke recovery, and neurorehabilitation -
-
PRESS RELEASE
TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
TUI delivers resilient Q3 underlying EBIT of €234.6m despite geopolitical headwinds and one-offs, reaffirms FY26 guidance. Financial report and strategic developments outlined -
-
PRESS RELEASE
Subdued demand weighs on Hawesko's business in the first half of the year – gross profit margin up – cost and efficiency progress taking effect – full-year 2026 guidance adjusted
Hawesko Holding SE reports lower revenue in H1 2026 due to subdued demand, but sees improved profit margin and cost efficiency progress. Full-year 2026 guidance adjusted amidst challenging market conditions -
-
PRESS RELEASE
Grand City Properties S.A. announces H1 2026 results with robust operations confirming FY 2026 guidance
Grand City Properties S.A. announces H1 2026 results with 3% net rental income growth and €0.52 FFO I per share. Company maintains solid financial position and reinstates €0.30 dividend per share for 2025 -
-
PRESS RELEASE
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year. Successful clinical development enhances Formycon's position in biosimilars
